Feng‐Ming Tien

Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax

Yuwen Wang, Cheng‐Hong Tsai, Chien‐Chin Lin et al. · Annals of Hematology · 2020 · 73 citations

Medicine, Hematology, Oncology +14

Clinical and microbiological characteristics of bloodstream infections among patients with haematological malignancies with and without neutropenia at a medical centre in northern Taiwan, 2008–2013

Chien‐Yuan Chen, Feng‐Ming Tien, Wang‐Huei Sheng et al. · International Journal of Antimicrobial Agents · 2017 · 68 citations

Life Sciences, Hematology, Infectious Diseases +17

Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML

Cheng‐Hong Tsai, Jih‐Luh Tang, Feng‐Ming Tien et al. · Blood Advances · 2021 · 49 citations · Full text

Medicine, Hematology, Oncology +17

GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia

Feng‐Ming Tien, Hsin‐An Hou, Cheng‐Hong Tsai et al. · Blood Cancer Journal · 2018 · 41 citations · Full text

Life Sciences, Genetics, Molecular Genetics +10

Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor‐risk factor in <i>de novo</i> acute myeloid leukemia patients

Feng‐Ming Tien, Hsin‐An Hou, Cheng‐Hong Tsai et al. · European Journal Of Haematology · 2018 · 40 citations

Life Sciences, Genetics, Hematology +17